Tempus AI (NASDAQ:TEM) Shares Break Above Fifty Day Moving Average – What’s Next?

Tempus AI, Inc. (NASDAQ:TEM)’s share price crossed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $71.32 and traded as high as $76.85. Tempus AI shares last traded at $76.05, with a volume of 6,279,076 shares traded.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the stock. Stifel Nicolaus reduced their target price on shares of Tempus AI from $60.00 to $50.00 and set a “hold” rating on the stock in a report on Monday, August 3rd. BTIG Research boosted their price target on shares of Tempus AI from $80.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday. Guggenheim increased their price objective on shares of Tempus AI from $65.00 to $92.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. Wall Street Zen raised shares of Tempus AI from a “sell” rating to a “hold” rating in a research report on Saturday, July 25th. Finally, The Goldman Sachs Group started coverage on shares of Tempus AI in a report on Monday, September 21st. They issued a “neutral” rating and a $75.00 price objective on the stock. Eleven research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $79.37.

Tempus AI Trading Up 8.0%

The company has a 50-day moving average price of $71.32 and a 200-day moving average price of $57.25. The firm has a market capitalization of $13.72 billion, a price-to-earnings ratio of -71.75 and a beta of 3.61. The company has a debt-to-equity ratio of 2.70, a quick ratio of 3.16 and a current ratio of 2.61.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Monday, November 2nd. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.16. The business had revenue of $411.54 million for the quarter, compared to the consensus estimate of $409.39 million. Tempus AI had a negative return on equity of 47.00% and a negative net margin of 12.54%. The business’s revenue for the quarter was up 23.1% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.46) EPS. As a group, research analysts forecast that Tempus AI, Inc. will post -1.20 EPS for the current fiscal year.

Insider Activity at Tempus AI

In other news, CEO Eric P. Lefkofsky sold 250,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 22nd. The shares were sold at an average price of $77.47, for a total transaction of $19,367,500.00. Following the completion of the sale, the chief executive officer owned 100,000 shares in the company, valued at approximately $7,747,000. The trade was a 71.43% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Andrew Polovin sold 22,148 shares of the company’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $49.61, for a total transaction of $1,098,762.28. Following the completion of the transaction, the executive vice president owned 146,067 shares of the company’s stock, valued at approximately $7,246,383.87. The trade was a 13.17% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 1,237,227 shares of company stock valued at $85,388,983. Company insiders own 24.26% of the company’s stock.

Institutional Investors Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Amova Asset Management Americas Inc. lifted its holdings in shares of Tempus AI by 23.4% during the first quarter. Amova Asset Management Americas Inc. now owns 4,326,313 shares of the company’s stock worth $195,549,000 after purchasing an additional 821,490 shares during the period. Pictet Asset Management Holding SA increased its stake in Tempus AI by 2,965.7% in the 3rd quarter. Pictet Asset Management Holding SA now owns 502,897 shares of the company’s stock valued at $41,233,000 after buying an additional 486,493 shares during the period. Eagle Health Investments LP acquired a new position in Tempus AI in the 1st quarter valued at $11,588,000. Aristotle Atlantic Partners LLC acquired a new position in Tempus AI in the 1st quarter valued at $6,179,000. Finally, International Assets Investment Management LLC raised its position in Tempus AI by 3,027.6% during the 3rd quarter. International Assets Investment Management LLC now owns 104,555 shares of the company’s stock worth $8,563,000 after buying an additional 101,212 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus AI is a technology company focused on applying data and artificial intelligence to healthcare, with an emphasis on precision medicine. Its platform combines clinical and molecular data to help physicians make more informed treatment decisions and support life-sciences research.

The company provides genomic sequencing and other diagnostic testing, software tools for analyzing patient data, and services that help identify clinical trial opportunities. Its work spans oncology and other areas of medicine, and it collaborates with healthcare providers and pharmaceutical and biotechnology companies.

Founded in 2015 by entrepreneur Eric Lefkofsky, Tempus is headquartered in Chicago.